A US Food and Drug Advisory (FDA) panel has voted 10 to 1 in favor of approval for AstraZeneca and Bristol-Myers Squibb’s diabetes drug dapagliflozin (Medscape)
Diabetes News Service
Glycosmedia App
A Glycosmedia iPhone/iPad App is available FREE from the iTunes store.
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
HONcode Standard
This site complies with the HONcode standard for trustworthy health information: verify here.
